Although there is yet to be a national pharmacovigilance centre in Kuwait, Reem Al-Essa launched a social media campaign to inform the public in her country about adverse effects and how to report them.
There is much more to pharmacovigilance than the collection of numbers and data. If we really want to create a culture of drug safety, says UMC’s Rebecca Chandler, we need to start listening to patients.
Uppsala Monitoring Centre has teamed up with the medicine regulatory authorities and National Pharmacovigilance centres of 20 countries to launch a social media campaign to raise awareness of the dangers of over-the-counter medicines.
Patient-derived reports add a richness to our understanding of medicine safety that would not be achieved by relying on healthcare professionals’ reports alone. Pharmacovigilance specialist Sten Olsson explains why.
By breaking down the wall between the pre- and post-marketing phases in a medication’s life-cycle, the safety profile of a new product would have more time to mature in the real world, argues Dr Agnes Kant from Lareb.
Using adverse event cluster analysis – a novel data-driven approach to signal exploration – UMC and the Danish pharmacovigilance centre have researched the extent of safety concerns associated with HPV vaccinations.